School of Medicine
Showing 61-70 of 70 Results
-
Alan M. Krensky, M.D.
Shelagh Galligan Professor in the School of Medicine, Emeritus
Current Research and Scholarly Interests Mechanisms and therapies for infection, cancer, autoimmunity and transplantation.
-
Nicole Krentz
Postdoctoral Research Fellow, Endocrinology and Metabolism
Bio Nicole completed her PhD at the University of British Columbia under the supervision of Francis Lynn in 2018. Her PhD research focused on pancreas development and endocrine cell genesis using mouse embryos and human embryonic stem cell differentiation as models. In 2018, Nicole joined Anna Gloyn?s group at the Wellcome Centre for Human Genetics at the University of Oxford. For her post-doctoral studies, Nicole is investigating the role of diabetes associated genes in pancreas development using genome-editing in human induced pluripotent stem cell models. In 2020, Nicole relocated to Stanford University where she will continue her post-doctoral research on the translation of genetic association signals for type 2 diabetes.
-
Akash Kumar
Adjunct Clinical Instructor, Pediatrics - Medical Genetics
Current Research and Scholarly Interests Akash is passionate about taking advances in genomics and applying them for patient care. After training in Chemical and Bioengineering at the University of Minnesota and Stanford University he started the Medical Scientist Training Program (MSTP) at the University of Washington and obtained a PhD in Genome Sciences. With his thesis advisor, Jay Shendure, Akash used next generation sequencing technologies to characterize the development and evolution of prostate cancer and glioblastoma. He also designed and implemented new methods using next-generation sequencing with applications for cancer genetics and prenatal genetic testing. He has published six first-author publications in journals including Nature Medicine, PNAS and Genome Medicine and is a co-inventor on one licensed patent. As a medical geneticist, Akash believes that the best approach to improve outcomes for children with complex congenital medical conditions stems from earlier diagnosis and intervention. To that effect, his current research goals are 1) to develop new genomic methods that identify children at risk for complex congenital diseases earlier, 2) to understand the molecular mechanisms of neurodevelopmental disease in children that may serve as potential avenues for treatment and 3) to improve access and implementation of genomics more broadly in the clinic.
Department Intranet